Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

SELL
$4.88 - $7.42 $52,933 - $80,484
-10,847 Reduced 67.37%
5,253 $35,000
Q3 2023

Dec 19, 2023

SELL
$4.86 - $7.23 $9,720 - $14,460
-2,000 Reduced 11.05%
16,100 $87,000
Q3 2023

Nov 15, 2023

SELL
$4.86 - $7.23 $9,720 - $14,460
-2,000 Reduced 11.05%
16,100 $88,000
Q2 2023

Dec 19, 2023

BUY
$5.68 - $10.34 $11,360 - $20,680
2,000 Added 12.42%
18,100 $122,000
Q2 2023

Aug 15, 2023

BUY
$5.68 - $10.34 $102,808 - $187,154
18,100 New
18,100 $123,000

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $487M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.